Can magnetic pulses to the brain ease borderline personality disorder?

NCT ID NCT07197502

Recruiting now Symptom relief Sponsor: University of California, Los Angeles Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Aug 11, 2026 · Updated 3 times

Summary

This study tests whether a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) can reduce symptoms of borderline personality disorder (BPD). Up to 30 adults with BPD will receive either real or sham TMS over several weeks. Researchers will track changes in symptoms, emotion regulation, and brain activity.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Transcranial Magnetic Stimulation (TMS)
What this could lead to: If it works, this could point toward a non-invasive brain stimulation treatment for borderline personality disorder symptoms.
What could go wrong: This is a small early-stage trial with only 30 people. It is testing a new targeting method, so results may not apply broadly, and the sham group can later receive active treatment, which may bias outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BORDERLINE PERSONALITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

borderline personality disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BORDERLINE PERSONALITY BORDERLINE PERSONALITY DISORDER BPD - BORDERLINE PERSONALITY DISORDER

Contacts and locations

Locations

Semel Institute for Neuroscience and Human Behavior at UCLA
RECRUITING

Los Angeles, California, 90024, United States
Semel Institute/ UCLA TMS
RECRUITING

Los Angeles, California, 90024, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.